---
title: "UK officials working nonstop to resolve NHS drug pricing dispute"
summary: "UK science minister Patrick Vallance said government officials are working nonstop to settle a dispute over drug prices with major pharma firms. The NHS is trying to raise the cost‑effectiveness limits for new medicines by about 25%. Big companies like AstraZeneca, MSD, and Eli Lilly have slowed or stopped investments in the UK after last year’s talks broke down. Some recent deals – Moderna, BioNTech and Convatec – give hope that the UK can still become a leading life‑sciences hub."
category: "NHS Healthcare Crisis"
section: "Business"
imageUrl: "https://media.guim.co.uk/1a481d7b2850e28630124230a12178365e12675e/519_0_5188_4150/500.jpg"
publishedAt: "2025-11-17T17:15:35Z"
guardianId: "business/2025/nov/17/uk-officials-working-to-resolve-nhs-drug-pricing-row-minister-says"
---

UK science minister Patrick Vallance said government officials are working nonstop to settle a dispute over drug prices with major pharma firms. The NHS is trying to raise the cost‑effectiveness limits for new medicines by about 25%. Big companies like AstraZeneca, MSD, and Eli Lilly have slowed or stopped investments in the UK after last year’s talks broke down. Some recent deals – Moderna, BioNTech and Convatec – give hope that the UK can still become a leading life‑sciences hub.
